About
R&D
Core Businesses
Products
Investors
News
Contact
English
- 简体中文

GLOBENEWSWIRE PRESS RELEASES

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

About Beroni
Our History
Board of Directors
Management Team
Vision, Mission, and Values

Core Businesses

Cell Therapy
Anti-Cancer Drugs
Infectious Diseases
E-Commerce

Products

By Beroni China
By Beroni Japan
By Beroni USA

website by chase e-Design

Close Menu

GLOBENEWSWIRE PRESS RELEASES

2021 Press Releases

2020 Press Releases

2019 Press Releases

About

Core Businesses

Products

Copyrights© Beroni Group 2019 | All rights reserved |

website by chase e-Design